Despite the CBD fanfare in 2019, the Food & Drug Administration still considers unregulated cannabidiol sales unlawful. At issue is whether CBD is “generally recognized as safe” (GRAS). So far, the FDA is flexing its jurisdictional muscle and saying, no.
